Profil bibliographique

Pau Lluch

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées

391Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Vasculitis and related conditionsOtitis Media and Relapsing PolychondritisSystemic Lupus Erythematosus ResearchCoagulation, Bradykinin, Polyphosphates, and AngioedemaIgG4-Related and Inflammatory Diseases

Publications récentes

2026 articleOpenAlex

Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patients

Adrián Martín-Gutiérrez, Javier Loricera, Diana Prieto-Peña, Vicente Aldasoro et autres

1 citationSeminars in Arthritis and Rheumatism

2025 articleOpenAlex

Tocilizumab monotherapy versus combined in aortitis associated with giant cell arteritis: Factors associated with imaging remission in a multicenter open-label study of 196 patients

A. Martín-Gutiérrez, J. Loricera, D. Prieto-Peña, Vicente Aldasoro et autres

3 citationsSeminars in Arthritis and Rheumatism

2020 articleOpenAlex

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro, Ignacio Villa et autres

34 citationsPubMed

Accès ouvert 2020 articleOpenAlex

OP0033 OPTIMIZATION OF TOCILIZUMAB THERAPY IN GIANT CELL ARTERITIS. A MULTICENTER REAL-LIFE STUDY OF 134 PATIENTS

Monica Calderón-Goercke, D. Prieto-Peña, Santos Castañeda, C. Moriano et autres

1 citationAnnals of the Rheumatic Diseases

2020 conference-abstractOpenAlex

THU0297 SERIOUS INFECTIONS IN 134 PATIENTS WITH GIANT CELL ARTERITIS WITH TOCILIZUMAB IN CLINICAL PRACTICE. FREQUENCY, TYPE AND CLINICAL ASSOCIATIONS

Monica Calderón-Goercke, D. Prieto-Peña, Santos Castañeda, C. Moriano et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2019 articleOpenAlex

AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS

Monica Calderón-Goercke, J. Loricera, D. Prieto-Peña, Vicente Aldasoro et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2019 conference-abstractOpenAlex

OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS

Monica Calderón-Goercke, J. Loricera, D. Prieto-Peña, Vicente Aldasoro et autres

2 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2019 articleOpenAlex

FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB

Monica Calderón-Goercke, J. Loricera, D. Prieto-Peña, Vicente Aldasoro et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2019 conference-abstractOpenAlex

SAT0220 USE OF TOCILIZUMAB IN AORTITIS. A MULTICENTER STUDY OF 79 PATIENTS

Monica Calderón-Goercke, J. Loricera, D. Prieto-Peña, Vicente Aldasoro et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2019 articleOpenAlex

FRI0276 TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS

Monica Calderón-Goercke, J. Loricera, D. Prieto-Peña, Vicente Aldasoro et autres

1 citationAnnals of the Rheumatic Diseases

Accès ouvert 2019 articleOpenAlex

SAT0219 EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS INDEPENDENTLY OF THE INICIAL PREDNISONE DOSE

Monica Calderón-Goercke, J. Loricera, D. Prieto-Peña, Vicente Aldasoro et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2019 articleOpenAlex

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro, Santos Castañeda et autres

109 citationsSeminars in Arthritis and Rheumatism

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.